Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
6653319
Publication Date
11-25-2003
Abstract
The present invention provides a general method to retard the precipitation inception time for poorly water-soluble camptothecin analogues from a supersaturated solution by a chemical conversion approach via pH alteration. This method is successfully utilized to prepare stable parenteral formulations for silatecan 7-t-butyldimethylsilyl-10-hydroxycamptothecin (DB-67), a poorly water-soluble lipophilic camptothecin analogue, in aqueous solutions containing β-cyclodextrin sulfobutyl ether (SBE-CD) or other solubilizing agents. The formulations manufactured by this method are more simple and cost-effective, of higher doses and better quality in terms of manufacture loss and formulation stability, and can be free of organic solvents (e.g., DMSO or N-methyl-2-pyrrolidinone).
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
10/216,883
Filing Date
08/12/2002
Recommended Citation
Xiang, Tiang-Xiang and Anderson, Bradley D., "Pharmaceutical Formulation for Poorly Water Soluble Camptothecin Analogues" (2003). Pharmaceutical Sciences Faculty Patents. 78.
https://uknowledge.uky.edu/ps_patents/78
